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Hypocholesterolemia is a significant predictor of death in a
cohort of chronic hemodialysis patients
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Hypocholesterolemia is a significant predictor of death in a tween low serum cholesterol and mortality in the general
cohort of chronic hemodialysis patients. population [7] and in dialysis patients [8, 9]. We have
Background. Although hypocholesterolemia is common in previously observed a higher prevalence of cerebral hem-chronic hemodialysis patients, its effect on survival has not
orrhage in both the general population [10] and chronicbeen studied in a large patients population.
dialysis patients who have low serum cholesterol [11].Methods. A cohort of chronic hemodialysis patients (N 
1167) was prospectively followed from January 1991 to January Few studies have examined the role of serum cholesterol
2001. The survival impact of this cohort, who were divided ac- in the prognosis of chronic dialysis patients. For this pur-
cording to different baseline levels of serum cholesterol, were pose, we studied a cohort of chronic hemodialysis pa-calculated with the multivariate Cox proportional hazard analy-
tients over a ten-year period.sis after adjusting for baseline clinical and laboratory variables.
In the present study, we examined the significance ofResults. During the study period, 567 (48.6%) patients died.
The mean (SD) baseline level of serum cholesterol was 171.0 baseline levels of serum cholesterol for the prognosis of
(40.8) mg/dL and ranged from 76 to 378 mg/dL. The five-year chronic hemodialysis patients after adjusting for con-
survival rate was highest (0.812) in the subgroup that had a
founding variables such as age, sex, presence of diabetesserum cholesterol range of 200 to 219 mg/dL and was lowest
mellitus, duration of dialysis, serum albumin, and body(0.608) in the subgroup with serum cholesterol values of 140
mg/dL. The five-year survival rate was 0.735 in the subgroup mass index. We also looked at the determinants of base-
with serum cholesterol of 220 mg/dL. Serum cholesterol was line levels of serum cholesterol.
a significant predictor of death with an adjusted hazards ratio
(95% confidence interval) was 0.939 (0.891 to 0.989). In a sub-
group of patients with serum albumin values 4.5 g/dL (N  METHODS
128), the adjusted hazards ratio was even greater at 1.370 (1.105
Cohort of chronic hemodialysis patientsto 1.692). Other than sex, body mass index and serum albumin
were significant determinants of baseline levels of serum cho- Patients (N 1243) who were on chronic hemodialysis
lesterol. in January 1991 were prospectively followed until Janu-Conclusions. Hypocholesterolemia was an independent pre-
ary 2001 (10 years).dictor of death in patients on chronic hemodialysis. This impact
of hypercholesterolemia on survival was only evident in a sub- Chronic hemodialysis patients were defined as those
group of patients whose serum albumin was more than 4.5 g/dL. who survived for at least one month while on a regularly
scheduled dialysis treatment. The Okinawa Dialysis Study
(OKIDS) registry contains the records of all dialysis pa-
Cardiovascular disease is a common cause of death in tients who have resided in Okinawa since 1971, and de-
chronic hemodialysis patients [1, 2] and hypercholester- tails of this registry have been published before [11–13].
olemia is a conventional risk factor of cardiovascular The registry includes patient name, sex, birth date, start
disease in the general population [3, 4]. However, serum date of dialysis, primary renal disease, and other perti-
cholesterol is often low in dialysis patients, probably nent data. The dialysis regimen in Okinawa is similar to
because of malnutrition and chronic inflammation [5, 6]. that in other parts of Japan [11–13]. The medical policy
Previous reports have noted a significant association be- and health care systems for dialysis therapy in Japan
were reviewed recently [14]. More than 83% of the pa-
tients in our OKIDS registry underwent dialysis threeKey words: hypoalbuminemia, hypercholesterolemia, dialysis, serum
cholesterol, risk factors in HD, Japan and hemodialysis. times per week. The dialysis period per session was 3.0
to 3.5 hours in 5.2%, 3.5 to 4.0 hours in 57.0%, 4.0 toReceived for publication September 5, 2001
5.0 hours in 10.0%, and more than 5.0 hours in 27.8%.and in revised form November 27, 2001
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Table 1. Demographics of the study patientsDialyzer reuse is exceptional in Japan. The baseline labo-
Number of patients 1167ratory values were obtained before routine hemodialysis
Men 680 (58.3%)in January 1991 [6, 13]. Laboratory and clinical data in-
Age at start of study years
cluding body weight, height, blood pressure, blood urea Mean 52.6
SD 14.6nitrogen (BUN), serum creatinine, total cholesterol, tri-
Range 15 to 92glyceride, total protein, serum albumin, and uric acid were
Duration of dialysis months
filed in the computer registry. In a subgroup of patients, Mean 62.8
SD 50.8data for C-reactive protein (CRP; N  158) also were
Range 1 to 233available [15]. Body height was measured within six Primary renal disease
months of the start of the study and body mass index Chronic glomerulonephritis 776 (66.5%)
Diabetes mellitus 208 (17.8%)(BMI) was defined as the ratio of weight to height
Systemic lupus erythematosus 18 (1.5%)squared (kg/m2). Causes of death were noted as infection, Polycystic kidney disease 28 (2.4%)
dialysis withdrawal, cardiac, sudden death, vascular, and Nephrosclerosis 58 (5.0%)
Others 79 (6.8%)others. Death associated with withdrawal occurred in
Outcome
patients who had severe cachexia or malnutrition or who Alive 600 (51.4%)
Dead 567 (48.6%)were hemodynamically unstable and thus unable to un-
dergo regular dialysis. The study period was from January 1991 to January 2001.
All patients were followed-up until death, renal trans-
plantation, transfer outside of Okinawa, or January 1,
2001. Seventy-six patients were excluded from the study:
serum cholesterol and serum albumin were not signifi-61 for renal transplantation, 14 transferred outside Oki-
cantly associated.nawa, and one for whom serum cholesterol data was
The ten-year mortality rate as differentiated by sub-unavailable. Therefore, 1167 patients, 680 men and 487
group of serum cholesterol level is shown in Figure 2.women, were enrolled in the present study. No patients
The mortality rate was lowest (35.9%) at the baseline
were lost to follow-up.
serum cholesterol level of 200 to 219 mg/dL and the
highest (57.2%) at the serum cholesterol of less than 140Statistical analysis
mg/dL. The survival curves by baseline level of serum
The unpaired t test and the chi square test were used cholesterol are shown in Figure 3. The five-year survival
to analyze differences in discrete variables between the rates were 60.8%, 68.3%, 69.7%, 78.5%, 81.2%, and
groups. Survival curves were calculated by the Kaplan- 73.5% from the lowest to the highest levels of baseline
Meier method. Cox proportional hazard analysis was serum cholesterol, respectively. The survival rate was
done to examine the significance of baseline level of best in the subgroup with a serum cholesterol range of
serum cholesterol as a predictor of prognosis for survival 200 to 219 mg/dL.
after adjusting for confounding variables with an SAS The distribution of causes of death is shown in Table 3.
model. Determinants of baseline levels of serum choles- Cardiovascular death such as death due to a cardiac
terol were examined by multivariate logistic analysis. event plus sudden death was highest (35.5%) in the group
Data are expressed as mean (SD). P values less than of the highest level of baseline serum cholesterol (220
0.05 were considered statistically significant. mg/dL). In contrast, cerebrovascular death was highest
(22.4%) in the lowest level of baseline serum cholesterol
(140 mg/dL).RESULTS
Results of the multivariate Cox proportional hazards
Demographics of the cohort of chronic hemodialysis analysis are summarized in Table 4. The hazards ratio (95%
patients are summarized in Table 1. The number of confidence interval; 95% CI) for subgroups according to
deaths was 567 (48.6%) over ten years. serum cholesterol levels was 0.939 (0.891 to 0.989), which
Baseline serum cholesterol levels were distributed as was significant (P  0.0180). With the lower serum cho-
shown in Figure 1. The mean SD level of serum choles- lesterol levels the mortality rate was high, and significant
terol was 171.0  40.8 mg/dL and ranged from 76 to 378 even after adjusting for serum albumin, BMI, and other
mg/dL. variables. The adjusted hazard ratio (95% CI) was 0.997
Several pertinent results are summarized by subgroups (0.996 to 0.999) for every mg/dL of serum cholesterol.
of the baseline serum cholesterol levels in Table 2. Serum Effects of serum cholesterol on survival were further
triglyceride levels increased in all groups with increases analyzed in relation to the baseline levels of serum albu-
in the serum cholesterol level except for the baseline 200 min (Table 5). The adjusted hazards ratio (95% CI) for
to 219 mg/dL group. However, the mean levels of serum those with serum albumin levels of 3.5 to 3.9 g/dL was
0.911 (0.839 to 0.989), which suggests an inverse relation-albumin remained constant, and the baseline levels of
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Fig. 1. Distribution of baseline levels of se-
rum cholesterol. Baseline data were obtained
before a regular hemodialysis session in Janu-
ary 1991.
Table 2. Mean (SD) levels of serum cholesterol, triglyceride, and albumin, and body mass index (BMI) at the baseline
grouped by serum cholesterol subgroup
Baseline levels of serum cholesterol mg/dL
140 140–159 160–179 180–199 200–219 220
N250 N249 N241 N163 N117 N147
Serum cholesterol mg/dL
Mean 121.2 149.5 169.0 189.0 208.6 246.4
SD 13.1 5.9 5.6 5.7 5.6 24.8
Range 76–139 140–159 160–179 180–199 200–219 220–378
Serum triglyceride mg/dL
Mean 108.8 130.3 150.9 202.0 191.3 238.1
SD 55.5 70.8 86.3 129.1 119.6 131.9
Range 15–424 22–538 37–591 39–964 52–773 52–924
Serum albumin g/dL
Mean 3.8 3.9 3.9 3.9 3.9 3.9
SD 0.5 0.5 0.5 0.4 0.4 0.5
Range 2.0–5.3 2.5–5.1 2.5–6.0 2.8–5.1 2.9–4.9 2.8–5.3
BMI kg/m2
Mean 20.9 21.2 21.3 22.5 22.2 22.8
SD 2.9 3.0 3.0 3.5 3.2 3.5
Range 15.2–33.4 14.3–32.1 14.6–31.0 14.2–35.2 16.6–37.7 14.9–34.0
ship between death risk and the level of serum choles- DISCUSSION
terol. However, in the subgroup of patients with serum The present study showed that hypocholesterolemia
albumin 4.5 g/dL, the adjusted hazards ratio was 1.370 is an independent predictor of death in chronic hemodi-
(1.109 to 1.692, P  0.0034), suggesting that there is a alysis patients. This is true even after adjusting for other
positive relationship between death risk and level of
possible confounders affecting baseline levels of serumserum cholesterol. In this group of patients, hypercholes-
cholesterol such as age [16], BMI, and serum albumin.terolemia was a significant risk factor for death.
Hypocholesterolemia is common in the chronic dialysisDeterminants of serum cholesterol were analyzed by
population; however, the mechanisms are not well delin-multivariate logistic analysis (Table 6). Other than sex,
eated. Cytokinemia, which may be related to impairedBMI and serum albumin were significant determinants of
removal of substances or to exposure of dialysis patientsserum cholesterol. Hypocholesterolemia was associated
to an occult chronic inflammation, is one of the causeswith significantly higher levels of serum CRP and a
higher prevalence of high CRP (Table 7). of hypocholesterolemia [5]. Declining serum cholesterol
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Fig. 2. Relationship between mortality rate
and subgroups of baseline levels of serum cho-
lesterol. Baseline data were obtained before
regular hemodialysis session in January 1991.
Fig. 3. Survival curves based on the baseline
groups divided by serum cholesterol level.
levels in chronic dialysis patients may be an indicator of A significant impact of hypocholesterolemia was pre-
viously suggested in both the general population [7] andeither declining health or dietary, metabolic, and other
clinical abnormalities similar to those associated with old dialysis patients [8, 9]. A low level of serum cholesterol
may indicate the existence of malnutrition and is oftenage [7]. Serum cholesterol level has been used an indicator
of energy intake [17]. In our dialysis population, the mean associated with a low level of serum albumin. Actually,
serum albumin level was strongly associated with serumlevel of serum cholesterol was significantly lower than that
of the general population in our region [3, 10]. cholesterol level in our dialysis patients (Table 6) and
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Table 3. Causes of death according to the baseline levels of serum cholesterol
Serum cholesterol mg/dL
140 140–159 160–179 180–199 200–219 220 Total
Cause of death N250 N249 N241 N163 N117 N147 N1167
Infection 23.1% 19.2% 17.3% 16.7% 19.0% 18.4% 19.4%
Withdrawal 21.0% 20.0% 13.6% 22.7% 14.3% 17.1% 18.5%
Cardiac 18.2% 28.5% 23.6% 28.8% 26.2% 27.6% 24.7%
Sudden death 4.2% 3.8% 5.5% 3.0% 7.1% 7.9% 4.9%
Cerebrovascular 22.4% 12.3% 20.0% 15.2% 11.9% 14.5% 16.9%
Others 11.2% 16.2% 20.0% 13.6% 21.4% 14.5% 15.5%
Number of deaths 143 130 110 66 42 76 567
The total percentage may not be 100% because of rounding.
Table 6. Determinants of baseline levels of serum cholesterolTable 4. Results of multivariate Cox proportional hazards analysis
of risk of death in chronic hemodialysis patients examined by multivariate logistic analysis
Variables Odds ratio 95% CI P valueVariables Hazard ratio 95% CI P value
Men vs. women 1.321 1.111–1.571 0.0016 Men vs. women 0.472 0.381–0.586 0.0001
Age years 0.999 0.992–1.007 NSAge years 1.060 1.052–1.067 0.0001
DM vs. non-DM 2.271 1.863–2.767 0.0001 DM vs. non-DM 0.929 0.696–1.239 NS
Serum albumin g/dL 1.627 1.293–2.047 0.0001Serum albumin g/dL 0.624 0.514–0.757 0.0001
BMI kg/m2 0.971 0.945–0.998 0.0364 BMI kg/m2 1.138 1.101–1.176 0.0001
HD duration months 1.002 1.000–1.004 NSHD duration months 1.028 1.005–1.051 0.0156
Serum cholesterola 0.939 0.891–0.989 0.0180 Abbreviations are: DM, diabetes mellitus; BMI, body mass index; HD, hemo-
dialysis. The odds ratio was calculated including variables in this Table.Abbreviations are: CI, confidence interval; DM, diabetes mellitus; BMI, body
mass index; HD, hemodialysis. The hazards ratio was calculated after adjusting
for other variables in this Table. Observation period was from January 1991 to
January 2001.
a Serum cholesterol was grouped into 6 groups as in Table 2
Table 7. Serum levels of C-reactive protein (CRP) grouped
by serum cholesterol level in January 1991
Serum cholesterol mg/dL
Table 5. Multivariate Cox proportional hazards analysis relating 160 160–199 200 Total
to the risk of death categorized by serum albumin subgroup
Number of patients 55 68 35 158of total cholesterol (TC)
CRP mg/dL
Mortality TC mg/dL Hazards Mean 1.3a 0.5 1.2 0.9
SAlb level rate % mean (SD) ratio 95% CI SD 1.9 0.7 2.3 1.7
% with high CRP 29.1b 13.3 22.9 20.9
3.5 g/dL (N200) 70.0 163.1 (45.1) 0.912 0.827–1.006
High CRP was defined as CRP  1.0 mg/dL.3.5–3.9 g/dL (N482) 53.7 171.5 (38.6) 0.911a 0.839–0.988
a P  0.007, b P  0.03 compared to serum cholesterol of 160–199 mg/dL4.0–4.4 g/dL (N354) 35.9 172.9 (40.8) 0.949 0.844–1.068
4.5 g/dL (N128) 31.3 176.2 (41.1) 1.370b 1.109–1.692
The effect of total cholesterol was evaluated in each subgroup related to
baseline levels of serum albumin (SAlb). The hazards ratio was calculated after
adjusting for sex, age, presence of diabetes mellitus, body mass index, and dura- serum cholesterol was also an independent, positive pre-
tion of dialysis. dictor of high risk for death in a subgroup of patientsa P  0.0249, b P  0.0034
with high serum albumin 4.5 g/dL, suggesting that the
higher the serum cholesterol the greater the risk of death
(Table 5). Death from cardiovascular events was more
in other studies [17]. Patients with hypoalbuminemia prevalent in patients with high levels of serum choles-
have a poor prognosis for survival [8, 13, 18], and they terol than in those with low levels (Table 3).
often have high CRP levels, suggesting chronic inflam- Recently, we observed a significant association be-
mation [19, 20]. In our study, a higher prevalence of tween coronary artery calcification and dyslipidemia in
elevated CRP was observed in patients with hypocholes- chronic hemodialysis patients [23]. Dialysis patients of-
terolemia (Table 7). Therefore, hypocholesterolemia may ten have altered lipid and lipoprotein profiles, a condi-
be another surrogate marker of health status of chronic tion known as uremic dyslipidemia. Such abnormalities
dialysis patients. Malnutrition may contribute to a poor may be an important factor for accelerated atherosclero-
prognosis by aggravating pre-existing heart failure and sis in dialysis patients [24, 25]. Unfortunately, lipid pro-
increasing the susceptibility to infection [20]. files such as high density lipoprotein (HDL)-cholesterol
Hypercholesterolemia is a conventional risk factor for and lipoprotein(a) were not available in the present study.
The long-term survival rate for the group of dialysiscardiovascular events [3, 21, 22]. In our dialysis patients,
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